AcuraStem, a patient-based biotechnology company developing disease-modifying therapies for amyotrophic lateral sclerosis (ALS), today announced it has received a two-year research grant from Target ...

Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

These included statins, prescribed to treat high cholesterol, and alpha blockers, also known as alpha adrenergic receptor ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

Researchers are to examine whether or not cheap cholesterol-busting statins could help people with motor neurone disease (MND) live longer. People with the progressive neurodegenerative disease ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years.

Salk researchers create epigenetic atlas of cell type-specific changes in the aging mouse brain, representing eight different brain regions and 36 different cell types to show clear epigenetic ...

CNW/ - Freegold Ventures Limited ("Freegold") (TSX: FVL) (OTCQX: FGOVF) is pleased to report results from six additional drill holes completed at its ...

The Grand Rapids-based research facility will use the funding to help support research related to neurological disorders, Rep. Scholten says.

Cheap drug used to treat high cholesterol could keep MND patients alive longer - Some 18 medications taken for other ...

High schools from all over south-central Kentucky got the chance to visit Southcentral Kentucky Community and Technical College and get hands-on experience through the Future Health Care Heroes Camp.